Arteether: Risks of two-week administration in Macaca mulatta

American Journal of Tropical Medicine and Hygiene

Volumn 56, Issue 4, 1997, Pages 390-396

  Petras, J M ^a   Kyle, D E ^a   Gettayacamin, M ^b   Young, G D ^c   Bauman, R A ^a   Webster, H K ^d   Corcoran, K D ^e   Peggins, J O ^a   Vane, M A ^a   Brewer, T G ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Armed Forces Research Institute of Medical Sciences San Francisco   (United States)

^c U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^d Becton Dickinson Co   (Singapore)

^e FITZSIMONS ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BRAIN STEM INJURY; CONTROLLED STUDY; LETHARGY; MACACA; MALARIA; MALE; NEUROANATOMY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NYSTAGMUS; REFLEX; RETICULAR FORMATION; VESTIBULAR SYSTEM;

ANIMALIA; MACACA; MACACA MULATTA; SESAMUM INDICUM;

EID: 0030935770     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.56.390     Document Type: Article

References (28)

1. Haworth J, 1988. The global distribution of malaria and the present control effort. Wernsdorfer WH, McGregor I, eds. Malaria: Principles and Practice of Malariology. Volume 2. Edinburgh: Churchill Livingstone, 1379-1420.
2. Foster SDF, 1991. The distribution and use of antimalarial drugs - Not a pretty picture. Targett, GAT, ed. Malaria: Waiting for the Vaccine. New York: John Wiley & Sons, 123-168.
3. Bradley DI, 1991. Malaria - Whence and wither? Targett, GAT, ed. Malaria: Waiting for the Vaccine. New York: John Wiley & Sons, 11-29.
4. Marsh K, Newton CRJC, Winstanley PA, Were IB, Kirkham F, 1991. Clinical malaria - New problems in patient management. Targett, GAT, ed. Malaria: Waiting for the Vaccine. New York: John Wiley & Sons, 31-48.
5. Beales PF, Goriup S, Litsios S, Molineaux L, Onori E, Pull IH, 1988. The planning of malaria control. Wernsdorfer WH, McGregor I, eds. Malaria: Principles and Practice of Malariology. Volume 2. Edinburgh: Churchill Livingstone, 1287-1334.
6. Gramiccia G, Beales PF, 1988. The history of malaria control and eradication. Wernsdorfer WH, McGregor I, eds. Malaria: Principles and Practice of Malariology. Volume 2. Edinburgh: Churchill Livingstone, 1335-1378.
7. Wernsdorfer WH, Trigg PI, 1988. Recent progress of malaria research: chemotherapy. Wernsdorfer WH, McGregor I, eds. Malaria: Principles and Practice of Malariology. Volume 2. Edinburgh: Churchill Livingstone, 1569-1574.
8. Oaks, SC Jr, Mitchell VS, Pearson GW, Carpenter CCJ, eds., 1991. Malaria: Obstacles and Opportunities. Washington, DC: National Academy Press.
9. Bjorkman A, 1991. Drug resistance - changing patterns. Targett, GAT, ed. Malaria: Waiting for the Vaccine. New York: John Wiley & Sons, 105-121.
10. Klayman DL, 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055.
11. Butler AR, Wu Y-L, 1992. Artemisinin (qinghaosu): a new type of antimalarial drug. Chem Soc Rev 21: 85-90.
12. Hein TT, White NJ, 1993. Qinghaosu. Lancet 341: 603-608.
13. White NJ, 1994. Artemisinin: current status. Trans R Soc Trop Med Hyg 88 (suppl 1): 3-4.
14. Nosten F, 1994. Artemisinin: large community studies. Trans R Soc Trop Med Hyg 88 (suppl 1): 45-46.
15. Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG, 1994. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 (suppl 1): 33-36.
16. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG, 1994. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51: 251-259.
17. Zahm DS, Munger BL, 1985. The innervation of the primate fungiform papilla: development, distribution, and changes following selective ablation. Brain Res 356: 147-186.
18. Cammemeyer J, 1960. The postmortem origin and mechanism of neuronal hyperchromatosis and nuclear pycnosis. Exp Neurol 2: 379-405.
19. Cammemeyer J, 1961. The importance of avoiding dark neurons in experimental neuropathology. Acta Neuropathol 1: 245-270.
20. Cammemeyer J, 1962. An evaluation of the significance of the "dark" neuron. Ergebn Anat Entwickl-Gesch 36: 1-61.
21. Drury RA, Wallington EA, 1980. Carleton's Histological Technique. Fifth edition. Oxford: Oxford University Press.
22. Kluver H, Barrera B, 1953. A method for combining stains of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12: 400-403.
23. Olszewski J, Baxter D, 1982. Cytoarchitecture of the Human Brain Stem. Basel: Karger.
24. ® User's Guide. Version 6, Fourth edition, Volume 2. Cary, NC: SAS Institute.
25. Benakis A, Schopfer S, Paris M, Plessas ChT, Karayannakos PE, Dondas I, Kotsarelis D, Plessas ST, Skalkeas G, 1991. Pharmacokinetics of arteether in dog. Eur J Drug Metab Pharmac 16: 325-328.
26. White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, Greenwood EM, 1992. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 339: 317-321.
27. Looareesuwan S, 1994. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 88 (suppl 1): 9-11.
28. Salako A, Walker O, Sowunmi A, Omokhodion SJ, Adio R, Oduola AMJ, 1994. Artemether in moderately severe and cerebral malaria in Nigerian children. Trans R Soc Trop Med Hyg 88 (suppl 1): 13-15.